JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Akt

A5072 GSK690693

Target: Akt|PKC|PKG|PKA|Prk

Summary: Pan-AKT inhibitor,ATP-competitive and potent

≥21.25 mg/mL
A5653 AT7867

Target: Akt|PKA|p70 rsk

Summary: Akt1/2/3 and p70S6K/PKA inhibitor

≥16.9 mg/mL
A1387 AZD5363
3 Citation

Target: Akt

Summary: AKT inhibitor,pyrrolopyrimidine derived

≥21.45 mg/mL
A8309 Perifosine
1 Citation

Target: Akt

Summary: Akt inhibitor
A8616 A-674563

Target: Cyclin-Dependent Kinases|Akt|GSK-3|ERK|PKC|PKA|RSK

Summary: Akt1/PKA/CDK2 inhibitor,potent and selective

insoluble in EtOH; ≥23.8 mg/mL
A8617 CCT128930 HCl

Target: Akt

Summary: AKT inhibitor

insoluble in H2O; ≥17.1 mg/mL
B7105 10-DEBC hydrochloride

Target: Akt

Summary: Akt inhibitor

Soluble in DMSO
A3006 GDC-0068 (RG7440)

Target: Akt

Summary: Pan-AKT inhibitor,highly selective

≥22.9 mg/mL
A3010 MK-2206 dihydrochloride
21 Citation

Target: Akt

Summary: Akt1/2/3 inhibitor

insoluble in EtOH; ≥12.01 mg/mL
A3149 AKT inhibitor VIII
2 Citation

Target: Akt

Summary: Allosteric Akt kinase inhibitor

insoluble in H2O; insoluble in EtOH; ≥9.2 mg/mL